Electromed, Inc. was founded by Mr. Robert Hansen and Mr. Craig Hansen and
incorporated in Minnesota in 1992. We hold numerous patents, which cover our
innovative means of administering High Frequency Chest Wall Oscillation, or
HFCWO, airway clearance therapy. We believe our system provides improved ease
of use, comfort and control at a cost that is comparable to current
Electromed has established itself as a leader in developing innovative airway
clearance therapy products for use by patients with compromised pulmonary
function. Our goal has been to make the HFCWO airway clearance treatments as
comfortable and convenient as possible so our patients can more easily tolerate
their regimen and be able to perform their treatments as readily as possible.
We created and introduced a portable, programmable, and multi-positional airway
clearance machine which employs HFCWO. For the past ten years, our primary
product, the SmartVest R Airway Clearance System (“SmartVest System”), along
with its predecessor product, the MedPulse Respiratory Vest System R, have been
providing daily respiratory therapy to patients in the U.S.
In order to maintain and expand our position in the market for airway clearance
therapy products, we have assembled an experienced team of employees with
expertise in health care, product development, manufacturing, marketing, sales,
and financial management. For example, more than 30% of our employees are
respiratory therapists. In addition, we engage over 300 respiratory therapists
and health professionals on a non-exclusive independent contractor basis to
educate and train customers on the SmartVest System. Our team also includes
several consultants who advise us on quality assurance, product development,
and financing, and who keep us apprised of industry developments and
opportunities in Europe.
We manufacture and sell products for use by chronically-ill patients who face
health risks due to pneumonia and mucus accumulation in the lungs, particularly
patients with cystic fibrosis, chronic obstructive pulmonary disease (“COPD”),
bronchiectasis, and neuro-muscular disorders. The purpose of our primary
product, the SmartVest System, is to loosen, mobilize, and release respiratory
secretions from the lungs. Our products are primarily used in the home health
care market, and we have recently begun to sell our products for use in
hospitals, which we refer to as “institutional sales.”
The SmartVest System features a programmable electro-mechanical pulse generator
and a pneumatic therapy garment, which together provide safe, comfortable, and
effective airway clearance therapy. We believe that the lightweight, portable
design allows patients greater freedom to travel and enjoy activities of daily
living, resulting in enhanced quality of life for patients using our SmartVest
System. A broad range of vest sizes for children and adults allow for tailored
fit and function. User-friendly controls allow children to administer their own
daily therapy under adult supervision.
For approximately ten years, we have marketed the SmartVest System and
predecessor models to patients suffering with cystic fibrosis (“CF”). CF is a
genetic disease in which normal mucus becomes thick and sticky, eventually
restricting the function of the lungs, pancreas, and liver. Cystic fibrosis
patients require daily respiratory therapy. This was traditionally provided by
a respiratory therapist, parent or family member who must “clap” or pound on a
patient’s chest and back to loosen secretions that build up in the respiratory
tract. Severe build-up can result in lung infections, scarring and ultimately
death due to the patient’s inability to absorb oxygen.
Electromed, Inc. was incorporated in Minnesota in 1992. Our corporate
headquarters are located at 500 Sixth Avenue NW, New Prague, Minnesota 56071.
Our telephone number is (952) 758-9299. Our websites can be found
at www.electromed.com and www.smartvest.com.